259
Views
4
CrossRef citations to date
0
Altmetric
Review

Interplay Between Genetic and Epigenetic Mechanisms in Rheumatoid Arthritis

, &
Pages 493-504 | Received 14 Oct 2016, Accepted 03 Jan 2017, Published online: 21 Mar 2017

References

  • Gabay C , MJN , Van LaarJM . Rheumatoid arthritis: pathogenesis and clinical features . In : EULAR Textbook on Rheumatic Diseases . The European League Against Rheumatism , Switzerland , 229 – 264 ( 2015 ).
  • Cojocaru M , CojocaruIM , SilosiI , VrabieCD , TanasescuR . Extra-articular manifestations in rheumatoid arthritis . Maedica (Buchar.)5 ( 4 ), 286 – 291 ( 2010 ).
  • Klarenbeek NB , AllaartCF , KerstensPJ , HuizingaTW , DijkmansBA . The BeSt story: on strategy trials in rheumatoid arthritis . Curr. Opin. Rheumatol.21 ( 3 ), 291 – 298 ( 2009 ).
  • Tsokos GC , LoMS , ReisPC , SullivanKE . New insights into the immunopathogenesis of systemic lupus erythematosus . Nat. Rev. Rheumatol.12 ( 12 ), 716 – 730 ( 2016 ).
  • Ruhrmann S , StridhP , KularL , JagodicM . Genomic imprinting: a missing piece of the multiple sclerosis puzzle?Int. J. Biochem. Cell. Biol.67 , 49 – 57 ( 2015 ).
  • Altorok N , KahalehB . Epigenetics and systemic sclerosis . Semin. Immunopathol.37 ( 5 ), 453 – 462 ( 2015 ).
  • Bluestone JA , HeroldK , EisenbarthG . Genetics, pathogenesis and clinical interventions in type 1 diabetes . Nature464 ( 7293 ), 1293 – 1300 ( 2010 ).
  • Lee A , QiaoY , GrigorievGet al. Tumor necrosis factor alpha induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts . Arthritis Rheum.65 ( 4 ), 928 – 938 ( 2013 ).
  • Viatte S , PlantD , RaychaudhuriS . Genetics and epigenetics of rheumatoid arthritis . Nat. Rev. Rheumatol.9 ( 3 ), 141 – 153 ( 2013 ).
  • Klareskog L , GregersenPK , HuizingaTW . Prevention of autoimmune rheumatic disease: state of the art and future perspectives . Ann. Rheum. Dis.69 ( 12 ), 2062 – 2066 ( 2010 ).
  • Reynisdottir G , KarimiR , JoshuaVet al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis . Arthritis Rheumatol.66 ( 1 ), 31 – 39 ( 2014 ).
  • Engler A , NiedererF , KleinKet al. SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts . J. Mol. Med. (Berl.)92 ( 7 ), 757 – 767 ( 2014 ).
  • Engler A , TangeC , Frank-BertonceljM , GayRE , GayS , OspeltC . Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts . J. Mol. Med. (Berl.)94 ( 2 ), 173 – 182 ( 2016 ).
  • Bosch-Presegue L , VaqueroA . Sirtuin-dependent epigenetic regulation in the maintenance of genome integrity . FEBS J.282 ( 9 ), 1745 – 1767 ( 2015 ).
  • Chabchoub G , UzE , MaalejAet al. Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases . Arthritis Res. Ther.11 ( 4 ), R106 ( 2009 ).
  • Liao J , LiangG , XieSet al. CD40L demethylation in CD4(+) T cells from women with rheumatoid arthritis . Clin. Immunol.145 ( 1 ), 13 – 18 ( 2012 ).
  • Soto ME , VallejoM , GuillenF , SimonJA , ArenaE , ReyesPA . Gender impact in systemic lupus erythematosus . Clin. Exp. Rheumatol.22 ( 6 ), 713 – 721 ( 2004 ).
  • Lu Q , WuA , TesmerL , RayD , YousifN , RichardsonB . Demethylation of CD40LG on the inactive X in T cells from women with lupus . J. Immunol.179 ( 9 ), 6352 – 6358 ( 2007 ).
  • Yarwood A , EyreS , WorthingtonJ . Genetic susceptibility to rheumatoid arthritis and its implications for novel drug discovery . Expert Opin. Drug. Discov.11 ( 8 ), 805 – 813 ( 2016 ).
  • Stahl EA , RaychaudhuriS , RemmersEFet al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci . Nat. Genet.42 ( 6 ), 508 – 514 ( 2010 ).
  • Okada Y , TeraoC , IkariKet al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population . Nat. Genet.44 ( 5 ), 511 – 516 ( 2012 ).
  • Eyre S , BowesJ , DiogoDet al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis . Nat. Genet.44 ( 12 ), 1336 – 1340 ( 2012 ).
  • Okada Y , WuD , TrynkaGet al. Genetics of rheumatoid arthritis contributes to biology and drug discovery . Nature506 ( 7488 ), 376 – 381 ( 2014 ).
  • Messemaker TC , Frank-BertonceljM , MarquesRBet al. A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels . Genes Immun.17 ( 2 ), 85 – 92 ( 2016 ).
  • Knevel R , KleinK , SomersKet al. Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis . Ann. Rheum. Dis.73 ( 11 ), 2038 – 2046 ( 2014 ).
  • Spain SL , BarrettJC . Strategies for fine-mapping complex traits . Hum. Mol. Genet.24 ( R1 ), R111 – R119 ( 2015 ).
  • Farh KK , MarsonA , ZhuJet al. Genetic and epigenetic fine mapping of causal autoimmune disease variants . Nature518 ( 7539 ), 337 – 343 ( 2015 ).
  • Trynka G , HuntKA , BockettNAet al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease . Nat. Genet.43 ( 12 ), 1193 – 1201 ( 2011 ).
  • Voight BF , KangHM , DingJet al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits . PLoS Genet.8 ( 8 ), e1002793 ( 2012 ).
  • Wellcome Trust Case Control C , MallerJB , McveanGet al.Bayesian refinement of association signals for 14 loci in 3 common diseases . Nat. Genet.44 ( 12 ), 1294 – 1301 ( 2012 ).
  • Visscher PM , BrownMA , MccarthyMI , YangJ . Five years of GWAS discovery . Am. J. Hum. Genet.90 ( 1 ), 7 – 24 ( 2012 ).
  • Tak YG , FarnhamPJ . Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome . Epigenetics Chromatin.8 , 57 ( 2015 ).
  • Kim TK , ShiekhattarR . Architectural and functional commonalities between enhancers and promoters . Cell162 ( 5 ), 948 – 959 ( 2015 ).
  • Furey TS . ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions . Nat. Rev. Genet.13 ( 12 ), 840 – 852 ( 2012 ).
  • Boyle AP , DavisS , ShulhaHPet al. High-resolution mapping and characterization of open chromatin across the genome . Cell132 ( 2 ), 311 – 322 ( 2008 ).
  • Buenrostro JD , GiresiPG , ZabaLC , ChangHY , GreenleafWJ . Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position . Nat. Methods10 ( 12 ), 1213 – 1218 ( 2013 ).
  • Li W , NotaniD , RosenfeldMG . Enhancers as non-coding RNA transcription units: recent insights and future perspectives . Nat. Rev. Genet.17 ( 4 ), 207 – 223 ( 2016 ).
  • Arner E , DaubCO , Vitting-SeerupKet al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells . Science347 ( 6225 ), 1010 – 1014 ( 2015 ).
  • Andersson R , GebhardC , Miguel-EscaladaIet al. An atlas of active enhancers across human cell types and tissues . Nature507 ( 7493 ), 455 – 461 ( 2014 ).
  • Consortium EP . An integrated encyclopedia of DNA elements in the human genome . Nature489 ( 7414 ), 57 – 74 ( 2012 ).
  • Roadmap Epigenomics C , KundajeA , MeulemanWet al.Integrative analysis of 111 reference human epigenomes . Nature518 ( 7539 ), 317 – 330 ( 2015 ).
  • Romanoski CE , GlassCK , StunnenbergHG , WilsonL , AlmouzniG . Epigenomics: roadmap for regulation . Nature518 ( 7539 ), 314 – 316 ( 2015 ).
  • Stunnenberg HG , HirstM , International Human Epigenome C . The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery . Cell167 ( 7 ), 1897 ( 2016 ).
  • Lizio M , HarshbargerJ , ShimojiHet al. Gateways to the FANTOM5 promoter level mammalian expression atlas . Genome Biol.16 , 22 ( 2015 ).
  • The FANTOM Consortium, the RIKEN PMI, CLST (DGT) . A promoter-level mammalian expression atlas . Nature507 ( 7493 ), 462 – 470 ( 2014 ).
  • Ward LD , KellisM . HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants . Nucleic Acids Res.40 , D930 – D934 ( 2012 ).
  • Boyle AP , HongEL , HariharanMet al. Annotation of functional variation in personal genomes using RegulomeDB . Genome Res.22 ( 9 ), 1790 – 1797 ( 2012 ).
  • Guo H , AhmedM , ZhangFet al. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer . Nat. Genet.48 ( 10 ), 1141 – 1150 ( 2016 ).
  • Musunuru K , StrongA , Frank-KamenetskyMet al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus . Nature466 ( 7307 ), 714 – 719 ( 2010 ).
  • Maurano MT , HumbertR , RynesEet al. Systematic localization of common disease-associated variation in regulatory DNA . Science337 ( 6099 ), 1190 – 1195 ( 2012 ).
  • Parker SC , StitzelML , TaylorDLet al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants . Proc. Natl Acad. Sci. USA110 ( 44 ), 17921 – 17926 ( 2013 ).
  • Pasquali L , GaultonKJ , Rodriguez-SeguiSAet al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants . Nat. Genet.46 ( 2 ), 136 – 143 ( 2014 ).
  • Walsh AM , WhitakerJW , HuangCCet al. Integrative genomic deconvolution of rheumatoid arthritis GWAS loci into gene and cell type associations . Genome Biol.17 , 79 ( 2016 ).
  • Trynka G , SandorC , HanBet al. Chromatin marks identify critical cell types for fine mapping complex trait variants . Nat. Genet.45 ( 2 ), 124 – 130 ( 2013 ).
  • Noss EH , NguyenHN , ChangSK , WattsGF , BrennerMB . Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types . Proc. Natl Acad. Sci. USA112 ( 48 ), 14948 – 14953 ( 2015 ).
  • Kurreeman FA , PadyukovL , MarquesRBet al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis . PLoS Med.4 ( 9 ), e278 ( 2007 ).
  • Plenge RM , SeielstadM , PadyukovLet al. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study . N. Engl. J. Med.357 ( 12 ), 1199 – 1209 ( 2007 ).
  • Dekker J , Marti-RenomMA , MirnyLA . Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data . Nat. Rev. Genet.14 ( 6 ), 390 – 403 ( 2013 ).
  • Matelot M , NoordermeerD . Determination of high-resolution 3D chromatin organization using circular chromosome conformation capture (4C-seq) . Methods Mol. Biol.1480 , 223 – 241 ( 2016 ).
  • Ferraiuolo MA , SanyalA , NaumovaN , DekkerJ , DostieJ . From cells to chromatin: capturing snapshots of genome organization with 5C technology . Methods58 ( 3 ), 255 – 267 ( 2012 ).
  • Rudan MV , HadjurS , SextonT . Detecting spatial chromatin organization by chromosome conformation capture ii: genome-wide profiling by Hi-C . Methods Mol. Biol. dio:10.1007/7651_2015_261 ( 2016 ) ( Epub ahead of print ).
  • Martin P , McgovernA , OrozcoGet al. Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci . Nat. Commun.6 , 10069 ( 2015 ).
  • Fujita F , TaniguchiY , KatoTet al. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling . Mol. Cell. Biol.23 ( 21 ), 7780 – 7793 ( 2003 ).
  • Fukasaka M , OriD , KawagoeTet al. Critical role of AZI2 in GM-CSF-induced dendritic cell differentiation . J. Immunol.190 ( 11 ), 5702 – 5711 ( 2013 ).
  • Maruyama K , FukasakaM , UematsuSet al. 5-Azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival . J. Biol. Chem.290 ( 15 ), 9377 – 9386 ( 2015 ).
  • Galloway A , SavelievA , LukasiakSet al. RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence . Science352 ( 6284 ), 453 – 459 ( 2016 ).
  • Neumann E , LefevreS , ZimmermannB , GayS , Muller-LadnerU . Rheumatoid arthritis progression mediated by activated synovial fibroblasts . Trends Mol. Med.16 ( 10 ), 458 – 468 ( 2010 ).
  • Klein K , GayS . Epigenetics in rheumatoid arthritis . Curr. Opin. Rheumatol.27 ( 1 ), 76 – 82 ( 2015 ).
  • Vicente R , NoelD , PersYM , ApparaillyF , JorgensenC . Deregulation and therapeutic potential of microRNAs in arthritic diseases . Nat. Rev. Rheumatol.12 ( 8 ), 496 ( 2016 ).
  • Karouzakis E , GayRE , MichelBA , GayS , NeidhartM . DNA hypomethylation in rheumatoid arthritis synovial fibroblasts . Arthritis Rheum.60 ( 12 ), 3613 – 3622 ( 2009 ).
  • Neidhart M , RethageJ , KuchenSet al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression . Arthritis Rheum.43 ( 12 ), 2634 – 2647 ( 2000 ).
  • Nakano K , WhitakerJW , BoyleDL , WangW , FiresteinGS . DNA methylome signature in rheumatoid arthritis . Ann. Rheum. Dis.72 ( 1 ), 110 – 117 ( 2013 ).
  • Karouzakis E , GayRE , GayS , NeidhartM . Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts . Arthritis Rheum.64 ( 6 ), 1809 – 1817 ( 2012 ).
  • Neidhart M , KarouzakisE , JungelA , GayRE , GayS . Inhibition of spermidine/spermine n1-acetyltransferase activity: a new therapeutic concept in rheumatoid arthritis . Arthritis Rheumatol.66 ( 7 ), 1723 – 1733 ( 2014 ).
  • Frank-Bertoncelj M , TrenkmannM , KleinKet al. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions . Nat. Commun. ( 2017 ) ( In press ).
  • Xu Y , BarterMJ , SwanDCet al. Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA . Osteoarthritis Cartilage20 ( 9 ), 1029 – 1038 ( 2012 ).
  • Loughlin J , ReynardLN . Osteoarthritis: epigenetics of articular cartilage in knee and hip OA . Nat. Rev. Rheumatol.11 ( 1 ), 6 – 7 ( 2015 ).
  • Ai R , HammakerD , BoyleDLet al. Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes . Nat. Commun.7 , 11849 ( 2016 ).
  • Ospelt C , ArmakaM , RussoGet al. Joint specific positional differences in coding andnoncoding transcriptome of synovial fibroblasts as a determinant ofsusceptibility of synovial joints to rheumatoid arthritis . Arthritis Rheumatol.66 ( Suppl. S10 ), S1216 ( 2014 ).
  • Gupta RA , ShahN , WangKCet al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis . Nature464 ( 7291 ), 1071 – 1076 ( 2010 ).
  • Serghiou S , KyriakopoulouA , IoannidisJP . Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis . Mol. Cancer15 ( 1 ), 50 ( 2016 ).
  • Song J , KimD , HanJ , KimY , LeeM , JinEJ . PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis . Clin. Exp. Med.15 ( 1 ), 121 – 126 ( 2014 ).
  • Pearson MJ , JonesSW . Long non-coding RNAs in the regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis . Arthritis Rheumatol.68 ( 11 ), 2575 – 2583 ( 2016 ).
  • Trigueros-Motos L , Gonzalez-GranadoJM , CheungCet al. Embryological-origin-dependent differences in homeobox expression in adult aorta: role in regional phenotypic variability and regulation of NF-kappaB activity . Arterioscler. Thromb. Vasc. Biol.33 ( 6 ), 1248 – 1256 ( 2013 ).
  • Pinnick KE , NicholsonG , ManolopoulosKNet al. Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications . Diabetes63 ( 11 ), 3785 – 3797 ( 2014 ).
  • Rinn JL , BondreC , GladstoneHB , BrownPO , ChangHY . Anatomic demarcation by positional variation in fibroblast gene expression programs . PLoS Genet.2 ( 7 ), e119 ( 2006 ).
  • Rinn JL , WangJK , AllenNet al. A dermal HOX transcriptional program regulates site-specific epidermal fate . Genes Dev.22 ( 3 ), 303 – 307 ( 2008 ).
  • Terranova R , AgherbiH , BonedA , MeresseS , DjabaliM . Histone and DNA methylation defects at HOX genes in mice expressing a SET domain-truncated form of Mll . Proc. Natl Acad. Sci. USA103 ( 17 ), 6629 – 6634 ( 2006 ).
  • Soshnikova N , DubouleD . Epigenetic temporal control of mouse Hox genes in vivo . Science324 ( 5932 ), 1320 – 1323 ( 2009 ).
  • Rinn JL , KerteszM , WangJKet al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs . Cell129 ( 7 ), 1311 – 1323 ( 2007 ).
  • Den Hollander W , RamosYF , BosSDet al. Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches . Ann. Rheum. Dis.73 ( 12 ), 2208 – 2212 ( 2014 ).
  • Sanchez R , ZhouMM . The role of human bromodomains in chromatin biology and gene transcription . Curr. Opin. Drug. Discov. Devel.12 ( 5 ), 659 – 665 ( 2009 ).
  • Dey A , ChitsazF , AbbasiA , MisteliT , OzatoK . The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis . Proc. Natl Acad. Sci. USA100 ( 15 ), 8758 – 8763 ( 2003 ).
  • Shang E , WangX , WenD , GreenbergDA , WolgemuthDJ . Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse . Dev. Dyn.238 ( 4 ), 908 – 917 ( 2009 ).
  • Houzelstein D , BullockSL , LynchDE , GrigorievaEF , WilsonVA , BeddingtonRS . Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4 . Mol. Cell. Biol.22 ( 11 ), 3794 – 3802 ( 2002 ).
  • Wang J , TadeoX , HouHet al. Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries . Genes Dev.27 ( 17 ), 1886 – 1902 ( 2013 ).
  • Mele DA , SalmeronA , GhoshS , HuangHR , BryantBM , LoraJM . BET bromodomain inhibition suppresses TH17-mediated pathology . J. Exp. Med.210 ( 11 ), 2181 – 2190 ( 2013 ).
  • Klein K , KabalaPA , GrabiecAMet al. The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts . Ann. Rheum. Dis.75 ( 2 ), 422 – 429 ( 2016 ).
  • Zhang QG , QianJ , ZhuYC . Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis . Immunol. Lett.166 ( 2 ), 103 – 108 ( 2015 ).
  • Xiao Y , LiangL , HuangMet al. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IkappaB kinase-dependent NF-kappaB activation in rheumatoid fibroblast-like synoviocytes . Rheumatology (Oxford).55 ( 1 ), 173 – 184 ( 2016 ).
  • Park-Min KH , LimE , LeeMJet al. Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation . Nat. Commun.5 , 5418 ( 2014 ).
  • Gallenkamp D , GelatoKA , HaendlerB , WeinmannH . Bromodomains and their pharmacological inhibitors . Chem. Med. Chem.9 ( 3 ), 438 – 464 ( 2014 ).
  • Ding N , HahN , YuRTet al. BRD4 is a novel therapeutic target for liver fibrosis . Proc. Natl Acad. Sci. USA112 ( 51 ), 15713 – 15718 ( 2015 ).
  • Xiong C , MasucciMV , ZhouXet al. Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis . Oncotarget7 ( 43 ), 69291 – 69308 ( 2016 ).
  • Fu W , FaracheJ , ClardySMet al. Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and beta cells . Elife3 , e04631 ( 2014 ).
  • Hui M , DohertyM , Da SilvaJ . Diagnostic strategies . In : EULAR Textbook of Rheumatic Diseases (1st Edition) . BMJ Publishing Group Ltd. , London, UK , 173 – 177 ( 2012 ).
  • Southam L , Rodriguez-LopezJ , WilkinsJMet al. An SNP in the 5’-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage . Hum. Mol. Genet.16 ( 18 ), 2226 – 2232 ( 2007 ).
  • Reynard LN , BuiC , SyddallCM , LoughlinJ . CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383 . Hum. Genet.133 ( 8 ), 1059 – 1073 ( 2014 ).
  • Kim H , KimJS . A guide to genome engineering with programmable nucleases . Nat. Rev. Genet.15 ( 5 ), 321 – 334 ( 2014 ).
  • Doudna JA , CharpentierE . Genome editing. The new frontier of genome engineering with CRISPR-Cas9 . Science346 ( 6213 ), 1258096 ( 2014 ).
  • Kochi Y , OkadaY , SuzukiAet al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility . Nat. Genet.42 ( 6 ), 515 – 519 ( 2010 ).
  • Li G , CuninP , WuDet al. The rheumatoid arthritis risk variant CCR6DNP regulates CCR6 via PARP-1 . PLoS Genet.12 ( 9 ), e1006292 ( 2016 ).
  • Liu J , GajT , YangYet al. Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells . Nat. Protoc.10 ( 11 ), 1842 – 1859 ( 2015 ).
  • Shalem O , SanjanaNE , ZhangF . High-throughput functional genomics using CRISPR-Cas9 . Nat. Rev. Genet.16 ( 5 ), 299 – 311 ( 2015 ).
  • Dang MN , BradfordCM , PozzilliP , LeslieRD . Methylation analysis in distinct immune cell subsets in type 1 diabetes . Methods Mol. Biol.1433 , 143 – 151 ( 2016 ).
  • Kapourani CA , SanguinettiG . Higher order methylation features for clustering and prediction in epigenomic studies . Bioinformatics32 ( 17 ), i405 – i412 ( 2016 ).
  • Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond . Nat. Rev. Genet.13 ( 7 ), 484 – 492 ( 2012 ).
  • Ai R , WhitakerJW , BoyleDLet al. DNA methylome signature in synoviocytes from patients with early rheumatoid arthritis compared to synoviocytes from patients with longstanding rheumatoid arthritis . Arthritis Rheumatol.67 ( 7 ), 1978 – 1980 ( 2015 ).
  • Glossop JR , EmesRD , NixonNBet al. Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T and B lymphocytes . Epigenomics8 ( 2 ), 209 – 224 ( 2016 ).
  • Liu Y , AryeeMJ , PadyukovLet al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis . Nat. Biotechnol.31 ( 2 ), 142 – 147 ( 2013 ).
  • Cribbs AP , KennedyA , PennHet al. Regulatory T cell function in rheumatoid arthritis is compromised by CTLA-4 promoter methylation resulting in a failure to activate the IDO pathway . Arthritis Rheumatol.66 ( 9 ), 2344 – 2354 ( 2014 ).
  • De Andres MC , Perez-PampinE , CalazaMet al. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate . Arthritis Res. Ther.17 , 233 ( 2015 ).
  • Cribbs AP , KennedyA , PennHet al. Methotrexate restores regulatory t cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis . Arthritis Rheumatol.67 ( 5 ), 1182 – 1192 ( 2015 ).
  • Glossop JR , NixonNB , EmesRDet al. DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis . Epigenomics doi:10.2217/epi-2016-0042 ( 2016 ) ( Epub ahead of print ).
  • Plant D , WebsterA , NairNet al. Differential methylation as a biomarker of response to etanercept in patients with rheumatoid arthritis . Arthritis Rheumatol.68 ( 6 ), 1353 – 1360 ( 2016 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.